A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically
Clinical trial NCT05826600 · TERMINATED
Trial details
- NCT number
- NCT05826600
- Sponsor
- iOmx Therapeutics AG
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2026-04-02
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.